REJECT DISEASE

DETECT THERAPIES

PROTECT PEOPLE

Biotect Services evaluates drug and biological products for efficacy using 2D and 3D in vitro models to advance your preclinical research.

Our Vision

To protect people from cancer and CNS diseases by advancing promising therapeutics from the bench to the clinic.

Our Goals

To use state-of-the-art tissue culture based bioanalytical methods to improve product characterization and predictability of clinical outcomes. Our professional team will work closely with our partners to design, implement, and report on translational research that moves viable products away from the bench and closer to the clinic.  

Discover how we can improve your therapeutic portfolio.

Our Clients

Non-profit organizations
Pharmaceutical companies
Biotechnology companies
Government agencies
Universities

B2B

Study design
RnD consulting
Translational research
Professional support

Why Choose Biotect

Skilled in Bio-assays
Creative and forward thinking
State of the art laboratories
Good laboratory practices

By combining cutting edge and traditional laboratory-based technologies, we seek to design and implement assays that are relatable to patient outcomes in clinical trials.

Who are we?

Biotect Services, Inc. is a contract research organization (CRO) specialty laboratory focused on preclinical assessment of oncology and CNS drug candidates.  We offer tailored model design and efficacy testing in 2D and 3D in-vitro cell-culture models. Biotect offers the advantage of rapid turnaround times, concise and timely reporting, and competitive pricing, which our clients appreciate.

This approach manifests our mission of improving patient outcomes by streamlining drug development in this unique preclinical space. Our customers have typically completed a proof-of-concept on their product candidate and need expert help developing their strategic product development plan; directing preclinical research; creating, validating, and running specialized assays; and, overseeing phase 1 and phase 2 clinical trials.

As a result of Biotect’s engagement, companies see fewer clinical failures, stay in regulatory compliance, reduce product development costs, and decrease time to market.  Our customers appreciate that as a team we are accessible, transparent, and professional.

Get in touch.

Thank you for visiting our website. Please contact us to request more information about our services or to provide feedback about our website.